Skip to main content
  • Subscribe
  • Register
  • Sign in
  • Membership
  • Insights
  • Events
  • About
  • Subscribe
  • Register
  • Sign in

Pfizer

Latest Articles

Shanghai Pharma Eyes $2.22B HK IPO

Opening Of Trading At The NYSE While Stocks Decline As Payrolls, Services Data Miss Estimates

Spurt of Initial Public Offerings Fails to Lift VC-Backed Companies

Udayan Gupta
2016-02-david-rothnie-paul-taubman-large.jpg

Takeover Veteran Paul Taubman Aims High with PJT Partners

David Rothnie
2015-06-hedge-fund-rising-stars-monica-lai-small.jpg

The 2015 Hedge Fund Rising Stars: Monica Lai

Tyler Davies
Pfizer And AstraZeneca's Billion Dollar Battle

The New Logic of M&A

Joseph G Paul
330x160-investing.jpg

Time to Invest in the Highest-Quality Companies

Vitaliy Katsenelson

U.S. M&A Could Rebound as Companies See Few Other Growth Options

Dan Weil

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

LinkedIn
X
Bluesky

develop build:2025-12-18   Login